GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tempest Therapeutics Inc (FRA:3OS) » Definitions » Interest Received

Tempest Therapeutics (FRA:3OS) Interest Received


View and export this data going back to 2021. Start your Free Trial

What is Tempest Therapeutics Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.


Tempest Therapeutics Business Description

Traded in Other Exchanges
Address
2000 Sierra Point Parkway, Suite 400, Brisbane, CA, USA, 94005
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.